» Articles » PMID: 12444919

The Transcriptional Repressor Gene Mad3 is a Novel Target for Regulation by E2F1

Overview
Journal Biochem J
Specialty Biochemistry
Date 2002 Nov 26
PMID 12444919
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Mad family proteins are transcriptional repressors that antagonize the activity of the c- Myc proto-oncogene product. Mad3 is expressed specifically during the S-phase of the cell cycle in both proliferating and differentiating cells, suggesting that its biological function is probably linked to processes that occur during this period. To determine the mechanisms that regulate the cell-cycle-specific transcription of Mad3, we used reporter gene assays in stably transfected fibroblasts. We show that the activation of Mad3 at the G1-S boundary is mediated by a single E2F (E2 promoter binding factor)-binding site within the 5'-flanking region of the gene. Mutation of this element eliminated transcriptional activation at S-phase, suggesting that the positively acting E2F proteins play a role in Mad3 regulation. Using electrophoretic mobility-shift assays and chromatin immunoprecipitation, we show that E2F1 binds to the Mad3 5'-flanking region both in vitro and in vivo. We thus identify Mad3 as a novel transcriptional target of E2F1.

Citing Articles

Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Prochownik E, Wang H Cells. 2022; 11(4).

PMID: 35203395 PMC: 8870482. DOI: 10.3390/cells11040747.


MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.

Zhang X, He X, Li Y, Xu Y, Chen W, Liu X Front Mol Biosci. 2021; 8:702206.

PMID: 34859046 PMC: 8632067. DOI: 10.3389/fmolb.2021.702206.


Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.

Zhang F, Liu L, Wu P, Li S, Wei D Transl Androl Urol. 2021; 10(2):785-796.

PMID: 33718080 PMC: 7947448. DOI: 10.21037/tau-20-1187.


Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.

Ngo T, Corrales A, Bourne T, Elmojahid S, Lam K, Diaz E Front Mol Biosci. 2019; 6:5.

PMID: 30838212 PMC: 6390498. DOI: 10.3389/fmolb.2019.00005.


Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.

Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y Pediatr Res. 2017; 82(3):527-535.

PMID: 28419087 PMC: 5766270. DOI: 10.1038/pr.2017.74.


References
1.
Wood M, McMahon S, Cole M . An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell. 2000; 5(2):321-30. DOI: 10.1016/s1097-2765(00)80427-x. View

2.
Prendergast G . Mechanisms of apoptosis by c-Myc. Oncogene. 1999; 18(19):2967-87. DOI: 10.1038/sj.onc.1202727. View

3.
Harbour J, Dean D . The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000; 14(19):2393-409. DOI: 10.1101/gad.813200. View

4.
Gaubatz S, Lindeman G, Ishida S, Jakoi L, Nevins J, Livingston D . E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell. 2000; 6(3):729-35. DOI: 10.1016/s1097-2765(00)00071-x. View

5.
Grandori C, Cowley S, James L, Eisenman R . The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol. 2000; 16:653-99. DOI: 10.1146/annurev.cellbio.16.1.653. View